{
    "clinical_study": {
        "@rank": "70444", 
        "arm_group": [
            {
                "arm_group_label": "BIVON group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "normal saline infusion"
            }
        ], 
        "brief_summary": {
            "textblock": "In this single-site, randomized, controlled and double-blind clinical trial, the\n      investigators evaluate the effect of sodium bicarbonate on prevention of acute kidney injury\n      in high risk patients undergoing off pump coronary bypass surgery."
        }, 
        "brief_title": "Effect of Sodium Bicarbonate on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass (OPCAB)", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients older than 20 years\n\n          -  scheduled for elective coronary artery bypass grafting.\n\n          -  preoperative estimated glomerular filtration rate (eGFR) : 30 ~ 89 %\n\n          -  LVEF < 35%\n\n          -  NYHA class III or IV\n\n          -  age > 70\n\n          -  DM\n\n          -  reoperation\n\n        Exclusion Criteria:\n\n          -  acute renal impairment\n\n          -  patients who receive dialysis\n\n          -  patients who receive steroid ( > 10mg/day prednisolon or equivalent)\n\n          -  hemo-alkalosis\n\n          -  hypernatremia\n\n          -  pulmonary edema\n\n          -  Hemoglobin < 10 mg/dL"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "162", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840241", 
            "org_study_id": "4-2012-0419"
        }, 
        "intervention": [
            {
                "arm_group_label": "BIVON group", 
                "description": "BIVON group were received 0.5 mmol/kg of sodium bicarbonate for 1hours after induction of anesthesia and following 0.15 mmol/kg of sodium bicarbonate during the operation.", 
                "intervention_name": "sodium bicarbonate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "intervention_name": "normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "sodium bicarbonate", 
            "acute kidney injury", 
            "OPCAB"
        ], 
        "lastchanged_date": "February 17, 2014", 
        "location": {
            "contact": {
                "email": "ylkwak@yuhs.ac", 
                "last_name": "Young Lan Kwak, MD", 
                "phone": "82-2-2228-8513"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of anesthesiology and pain medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "ylkwak@yuhs.ac", 
            "last_name": "Young Lan Kwak, MD", 
            "phone": "82-2-2228-8513"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The diagnostic criteria for AKI is followed by AKIN criteria (absolutely increase in the SCr concentration \u2265 0.3 mg/dL from baseline, \u2265 50% increase in the SCr concentration within 48 hours after operation).", 
            "measure": "compare the incidence of acute kidney injury", 
            "safety_issue": "No", 
            "time_frame": "Change of Indexes of renal function including SCr, cystatin C, creatinine clearance from 24 hrs before operation to postoperative day (POD) 5."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840241"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}